var _paq = window._paq = window._paq || []; /* tracker methods like "setCustomDimension" should be called before "trackPageView" */ _paq.push(['trackPageView']); _paq.push(['enableLinkTracking']); (function() { var u="https://rwrregs.matomo.cloud/"; _paq.push(['setTrackerUrl', u+'matomo.php']); _paq.push(['setSiteId', '1']); var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.data-privacy-src='//cdn.matomo.cloud/rwrregs.matomo.cloud/matomo.js'; s.parentNode.insertBefore(g,s); })();

USA | FDA Accepts Wearable-Derived Foot-Drop Measure into ISTAND — Digital Outcomes Advance in Rare-Disease Development

Please login to view this page.

USA | FDA Accepts Wearable-Derived Foot-Drop Measure into ISTAND — Digital Outcomes Advance in Rare-Disease Development2026-10-18T12:59:39+00:00

USA | Natural-History Evidence Supports FDA Approval of First Gene Therapy for Sanfilippo Syndrome Type A

Please login to view this page.

USA | Natural-History Evidence Supports FDA Approval of First Gene Therapy for Sanfilippo Syndrome Type A2026-10-18T12:22:51+00:00

USA | FDA Explores GenAI Medical Device Framework — RWD Could Shape Premarket and Postmarket Evidence

Please login to view this page.

USA | FDA Explores GenAI Medical Device Framework — RWD Could Shape Premarket and Postmarket Evidence2026-09-12T14:52:08+00:00

USA | Reagan-Udall Foundation Meeting Summary Highlights Real-World Data Challenges for At-Home Diagnostics

Please login to view this page.

USA | Reagan-Udall Foundation Meeting Summary Highlights Real-World Data Challenges for At-Home Diagnostics2026-08-10T17:32:46+00:00

USA | FDA Reissues Draft Guidance on Substantial Evidence of Effectiveness — Non-Interventional Studies Expressly Recognised Within the Adequate and Well-Controlled Investigation Framework

Please login to view this page.

USA | FDA Reissues Draft Guidance on Substantial Evidence of Effectiveness — Non-Interventional Studies Expressly Recognised Within the Adequate and Well-Controlled Investigation Framework2026-08-10T16:40:04+00:00

USA | FDA Finalises Post-Approval Pregnancy Safety Studies Guidance — Strengthening Expectations for Pregnancy Registries, Complementary RWD Studies and Global Pregnancy Safety Evidence Generation

Please login to view this page.

USA | FDA Finalises Post-Approval Pregnancy Safety Studies Guidance — Strengthening Expectations for Pregnancy Registries, Complementary RWD Studies and Global Pregnancy Safety Evidence Generation2026-06-12T10:54:30+00:00
Go to Top